Stay updated on Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Sign up to get notified when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.
Latest updates to the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2.SummaryDifference0.1%
- Check21 days agoChange DetectedA new PubMed-listed publication reference was added and an older entry was removed in the Publications section, and the record version was updated to v3.3.1.SummaryDifference0.2%
- Check29 days agoChange DetectedDeletion of the site-wide notice about a lapse in government funding and potential data delays, including links to cc.nih.gov and opm.gov.SummaryDifference0.4%
- Check43 days agoChange DetectedThe new screenshot shows only minor formatting and layout tweaks with no changes to core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check50 days agoChange DetectedA new related publication by ARAMIS investigators was added to the Publications section: Onset to Treatment Time and Early Neurological Deterioration of Dual Antiplatelet Therapy Versus Alteplase in Minor Stroke. The addition does not alter the study design or reported outcomes.SummaryDifference0.1%
- Check64 days agoChange Detected• Replaces an online-ahead-of-print citation with a full published citation including Epub date. The core reference details remain the same; the update confirms finalized publication status and date.SummaryDifference0.5%
Stay in the know with updates to Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.